Skip to content
Research/Bioregulators/Cartalax

Cartalax

compound

preliminary evidencePublic

Synthetic tripeptide bioregulator targeting cartilage and connective tissue. Reduces senescence markers (p16, p21, p53), increases SIRT6, promotes cartilage regeneration. Sequence: Ala-Glu-Asp.

Category: Bioregulators·Updated 5/19/2026
OverviewScienceClinicalSafetyPapersProtocolsOutcomes

Cartalax

Synthetic tripeptide bioregulator targeting cartilage and connective tissue. Reduces senescence markers (p16, p21, p53), increases SIRT6, promotes cartilage regeneration. Sequence: Ala-Glu-Asp.

ScienceComing soon
ClinicalComing soon
SafetyComing soon
PapersComing soon
ProtocolsComing soon
OutcomesComing soon